Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a
Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului
Yüklə 4,39 Mb.
|
- Bu səhifədəki naviqasiya:
- SUBLISTA C2-P9: PROGRAM NAŢIONAL DE TRANSPLANT DE ORGANE, ŢESUTURI ŞI CELULE DE ORIGINE UMANĂ. P9.6 TRANSPLANT PULMONAR
| Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________ DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA10 SIROLIMUS COMPR. FILM. 1 mg RAPAMUNE 1 mg 1 mg WYETH EUROPA LTD. ________________________________________________________________________________ ______________________________________________________________________________ | 989 |L04AX01| AZATHIOPRINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AX01 AZATHIOPRINUM COMPR. FILM. 50 mg IMURAN(R) 50 mg THE WELLCOME FOUNDATION LTD.
________________________________________________________________________________ ______________________________________________________________________________ | 990 |M05BA04| ACIDUM ALENDRONICUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ M05BA04 ACIDUM ALENDRONICUM COMPR. 10 mg FOSAMAX 10 mg 10 mg MERCK SHARP & DOHME S.R.L.
TEVA NAT 70 mg TEVA PHARMACEUTICALS SRL M05BA04 ACIDUM ALENDRONICUM COMPR. 70 mg FOSAMAX 70 mg 70 mg MERCK SHARP & DOHME S.R.L. ________________________________________________________________________________
| 991 |N02AB02| PETHIDINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ N02AB02 PETHIDINUM SOL. INJ. 50 mg/ml MIALGIN(R) 100 mg/2 ml 50 mg/ml ZENTIVA SA ________________________________________________________________________________ ______________________________________________________________________________ | 993 |B01AB08| REVIPARINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ B01AB08 REVIPARINUM SOL. INJ. CLIVARIN (R) 1432 UI/0.25 ml 1432 ui/0.25 ml ABBOTT GMBH & CO. KG CLIVARIN(R) 1432 UI/0.25 ml 1432 ui/0.25 ml ABBOTT GMBH & CO. KG B01AB08 REVIPARINUM SOL. INJ. CLIVARIN (R) 3436 UI/0,6 ml 3436 ui/0.6 ml ABBOTT GMBH & CO. KG CLIVARIN(R) 3436 UI/0,6 ml 3436 ui/0.6 ml ABBOTT GMBH & CO. KG ________________________________________________________________________________ ______________________________________________________________________________ | 994 |B05AA06| POLYGELINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ B05AA06 POLYGELINUM SOL. PERF. 3.5% HAEMACCEL 3.5% THERASELECT GMBH ________________________________________________________________________________ ______________________________________________________________________________ | 995 |J01XX08| LINEZOLIDUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01XX08 LINEZOLIDUM GRAN. PT. SUSP. ORALA ZYVOXID(R) 100 mg/5 ml PFIZER EUROPE MA EEI ZYVOXID(R) 100 mg/5 ml PFIZER EUROPE MA EEIG J01XX08 LINEZOLIDUM SOL. PERF. ZYVOXID(R) 2 mg/ml PFIZER EUROPE MA EEI ZYVOXID(R) 2 mg/ml PFIZER EUROPE MA EEIG
ZYVOXID(R) 600 mg PFIZER EUROPE MA EEI ZYVOXID(R) 600 mg PFIZER EUROPE MA EEIG ________________________________________________________________________________ ______________________________________________________________________________ | 996 |J02AC03| VORICONAZOLUM** | Protocol: J012B | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J02AC03 VORICONAZOLUM COMPR. FILM. VFEND(R) 200 mg PFIZER LIMITED VFEND 200 mg 200 mg PFIZER LTD. J02AC03 VORICONAZOLUM PULB. PT. SOL. PERF. VFEND(R) 200 mg PFIZER LIMITED VFEND 200 mg 200 mg PFIZER LTD.
VFEND(R) 40 mg/ml 40 mg/ml PFIZER LIMITED VFEND 40 mg/ml 40 mg/ml PFIZER LTD.
VFEND(R) 50 mg PFIZER LIMITED VFEND 50 mg 50 mg PFIZER LTD. ________________________________________________________________________________ ______________________________________________________________________________ | 998 |J05AB14| VALGANCICLOVIRUM** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J05AB14 VALGANCICLOVIRUM COMPR. FILM. 450 mg VALCYTE(R) 450 mg 450 mg ROCHE ROMANIA SRL
VALCYTE(R) 450 mg 450 mg ROCHE ROMANIA SRL ________________________________________________________________________________
| 999 |B01AB05| ENOXAPARINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ B01AB05 ENOXAPARINUM SOL. INJ. 2000 ui anti-Xa/0.2 ml CLEXANE 2000 ui 2000 ui anti-Xa/0.2 ml LAB. AVENTIS anti-Xa/0.2 ml
anti-Xa/0,4ml CLEXANE 4000 ui 4000 ui anti-Xa/0,4 ml LAB. AVENTIS anti-Xa/0.4 ml B01AB05 ENOXAPARINUM SOL. INJ. 6000 ui anti-Xa/0.6 ml CLEXANE 6000 ui 6000 ui anti-Xa/0.6 ml LAB. AVENTIS anti-Xa/0.6 ml B01AB05 ENOXAPARINUM SOL. INJ. 8000 ui anti-Xa/0.8 ml CLEXANE 8000 ui 8000 ui anti-Xa/0.8 ml LAB. AVENTIS anti-Xa/0.8 ml B01AB05 ENOXAPARINUM SOL. INJ. 2000 ui anti-Xa/0.2 ml CLEXANE 2000 ui 2000 ui anti-Xa/0.2 ml LAB. AVENTIS anti-Xa/0.2 ml B01AB05 ENOXAPARINUM SOL. INJ. 4000 ui anti-Xa/0,4 ml CLEXANE 4000 ui 4000 ui anti-Xa/0,4 ml LAB. AVENTIS anti-Xa/0.4 ml B01AB05 ENOXAPARINUM SOL. INJ. 6000 ui anti-Xa/0.6 ml CLEXANE 6000 ui 6000 ui anti-Xa/0.6 ml LAB. AVENTIS anti-Xa/0.6 ml ________________________________________________________________________________
| 1000 |B01AB08| REVIPARINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ B01AB08 REVIPARINUM SOL. INJ. 1432 ui/0.25 ml CLIVARIN(R) 1432 UI/0.25 ml 1432 ui/0.25 ml ABBOTT GMBH & CO. KG
CLIVARIN(R) 3436 UI/0,6 ml 3436 ui/0.6 ml ABBOTT GMBH & CO. KG ________________________________________________________________________________
| 1002 |C01CA24| EPINEPHRINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ C01CA24 EPINEPHRINUM SOL. INJ. 1 mg/ml ADRENALINA 1 mg 1 mg/ml TERAPIA SA ________________________________________________________________________________ ______________________________________________________________________________ | 1003 |J01CR05| PIPERACILLINUM + TAZOBACTAMUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01CR05 PIPERACILLINUM + LIOF. PT. SOL. INJ. TAZOBACTAMUM TAZOCIN 2,25 WYETH LEDERLE PHARMA GMBH TAZOCIN 4,5 WYETH LEDERLE PHARMA GMBH ________________________________________________________________________________ ______________________________________________________________________________ | 1004 |J01XX08| LINEZOLIDUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01XX08 LINEZOLIDUM GRAN. PT. SUSP. ORALA 100 mg/5 ml ZYVOXID(R) 100 mg/5 ml PFIZER EUROPE MA EEIG
ZYVOXID(R) 2 mg/ml PFIZER EUROPE MA EEIG J01XX08 LINEZOLIDUM COMPR. FILM. 600 mg ZYVOXID(R) 600 mg PFIZER EUROPE MA EEIG ________________________________________________________________________________
| 1005 |J02AC01| FLUCONAZOLUM | | |_______|_______|____________________________________________|_________________|
Yüklə 4,39 Mb. Dostları ilə paylaş:
|